Company / Assets per Share
Monte Rosa Therapeutics, Inc. Assets per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$5.94
FY2024
5-year range
$5.91 / $32.55
FY2020-FY2024
Trend
+0.4%
vs FY2023
Sector context
#137 of 210
Health Care
What the data says
At $5.94, Monte Rosa Therapeutics, Inc.'s assets per share ranks #137 of 210 in the Health Care sector. Assets per Share returned to growth in FY2024 after 3 years of decline, reaching $5.94.
Based on SEC 10-K filings.
5.94 in FY2024 with a 3-year CAGR of -26.0%.
Declined from $7.25 to $5.94 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -26.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#137 of 210 in Health CareTop 65% of 210This company $5.94 Sector average $353.15
▼
-98.3% below sector average
Key checks
Key Insights
- In FY2024, assets per share increased 0.4% year-over-year.
- Ranks #137 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $5.94 | +0.4% |
| FY2023 | $5.91 | -18.5% |
| FY2022 | $7.25 | -50.5% |
| FY2021 | $14.65 | -55.0% |
| FY2020 | $32.55 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026